Sodium Starch Glycolate Market Size, Share, and Industry Analysis, By Source (Potato, Corn Starch, and Wheat), By End Use (Pharmaceutical, Food & Beverage, Personal Care & Cosmetics, and Others), and Regional Forecast, 2024-2032

Sodium starch glycolate is a widely used pharmaceutical excipient, primarily functioning as a disintegrant in solid oral dosage forms. It is a sodium salt of carboxymethyl ether of starch, characterized by its high swelling capacity when in contact with water. This property enables rapid disintegration of tablets and capsules, promoting quick release and absorption of active pharmaceutical ingredients, thereby enhancing drug efficacy and bioavailability.

Segmentation:

Key Insights

The report covers the following key insights:

• Key Emerging Trends – For Major Regions


• Key Developments: Mergers, Acquisition, Partnerships


• Latest Technological Advancements


• Insights on Sustainability


• Porters Five Forces Analysis


• Impact of COVID-19 on the Market

Analysis by Source

By source, the market is segmented into potato, corn starch, and wheat. The Potato segment holds a significant share of the global Sodium Starch Glycolate market. Potato-based sodium starch glycolate is the leading segment due to its superior swelling capacity and rapid disintegration properties. It is preferred in many pharmaceutical formulations for its effectiveness and reliability. The potato starch source is particularly popular in Europe and North America, where potato cultivation is widespread. Interestingly, potato starch has a larger granule starch size compared to other sources, which can affect its function ability in certain applications.

Corn starch is widely used due to its abundance and cost-effectiveness. Corn-based sodium starch glycolate is often chosen for its consistent quality and performance across various pharmaceutical formulations. It also offers good stability and compatibility with a wide range of active pharmaceutical ingredients. The smaller granule size of cornstarch can be beneficial in certain applications where a smoother texture is desired. Further, the non-GMO status of some corn-based products is increasingly valued in both pharmaceutical and personal care applications, driving demand in these sectors.

• According to the U.S. Department of Agriculture (National Agricultural Statistics Service), the U.S. produced 15.3 billion bushels of corn in 2023.

Analysis by End Use

By end use, the market is segmented into pharmaceutical, food & beverage, personal care & cosmetics, and others. The Pharmaceutical segment holds a significant share of the global Sodium Starch Glycolate market. The pharmaceutical industry is the dominant end-use segment for sodium starch glycolate. It is extensively used as a disintegrant in tablet and capsule formulations across various therapeutic areas.

• The rising pharmaceutical market is creating a significant opportunity for the market. Its use is particularly prevalent in generic drug formulations, which are experiencing rapid growth globally.


• The increasing focus on fast-dissolving tablets and orally disintegrating formulations further boosts the demand for sodium starch glycolate in this sector.


• Moreover, its compatibility with a wide range of active ingredients and excipients makes it a versatile choice for formulators across different therapeutic categories.

In personal care and cosmetics, it is used as a thickener, stabilizer, and adsorbent in products, such as creams and lotions. In personal care products, it is valued for its ability to improve texture, increase viscosity, and enhance the formulation. The trends toward natural and plant-based ingredients in cosmetics have further boosted the appeal of sodium starch glycolate. Additionally, its role in improving the stability and shelf-life of cosmetic formulations makes it an attractive ingredient for manufacturers looking to enhance product quality and longevity.

• The global cosmetics market size was valued at USD 374.18 billion in 2023 and is projected to grow from USD 393.75 billion in 2024 to USD 758.05 billion by 2032, exhibiting a CAGR of 9.8% during the forecast period.

Regional Analysis

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds a significant share of the Sodium Starch Glycolate market. This dominance stems from its robust pharmaceutical industry, advanced healthcare infrastructure, and stringent regulatory environment. The region’s significant investment in R7D, growing generic drug market, and thriving cosmetics sector further boost demand. Additionally, the U.S. position as the world's largest corn producer ensures a steady raw material supply.

The major Sodium Starch Glycolate market consumers by region are China, Japan, and India in Asia Pacific; the U.S. & Canada in North America; Germany and France in Europe; and Saudi Arabia and UAE in the Middle East.

• In the U.S., spending on specialty drugs in 2021 was USD 284.9 billion for all sectors, which was 49.4% of total prescription expenditures. Specialty drug expenditures increased 8.7% in 2021 compared to 2020.


• According to the European Federation of Pharmaceutical Industries and Associations, in 2021, North America accounted for 49.1% of world pharmaceutical sales, compared to 23.4% in Europe.

Key Players Covered

The report will include the profiles of key players, such as DFE Pharma, Roquette Frères, JRS PHARMA, Ashland, Merck KGaA, Parchem, Patel Chem Specialties Pvt Ltd (PCSPL), Amishi Drugs & Chemicals Pvt Ltd, Colorcon, and BASF SE.